U.S. Court of Appeals for the Federal Circuit
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.
This writing
- Type
- Opinion
- Filed
- April 11, 2024
- Case
- Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 22-2153 Document: 71 Page: 1 Filed: 04/11/2024 United States Court of Appeals for the Federal Circuit ______________________ SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., BAUSCH HEALTH IRELAND LTD., ALFASIGMA S.P.A., Plaintiffs-Appellants v. NORWICH PHARMACEUTICALS INC., Defendant-Cross-Appellant ______________________ 2022…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Read the full document (court PDF)
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | April 11, 2024 |